On Thursday shares of Eltek Ltd. (NASDAQ:ELTK) closed at $1.07. Company’s sales growth for last 5 years was 3.10%. On 2 April, Eltek Ltd. (NASDAQ:ELTK) announced that it filed its annual report, containing audited consolidated financial statements for the year ended December 31, 2014, with the U.S. Securities and Exchange Commission. Revenues for the full year ended December 31, 2014 were $46.6 million compared to revenues of $50.2 million recorded in 2013.
Emerson Electric Co. (NYSE:EMR) in last trading activity moved down -0.63% to close at $55.54. Company weekly performance is -1.65% while its quarterly performance stands at -9.29%. Emerson Electric Co. (NYSE:EMR) is -18.28% away from its 52 week high. Emerson Electric Co. (NYSE:EMR) had its target price lowered by Barclays from $66.00 to $63.00 in a research note released on Tuesday morning. They currently have an equal weight rating on the stock.
On Thursday shares of Verizon Communications Inc. (NYSE:VZ) closed at $49.47. Company’s sales growth for last 5 years was 3.30% and EPS growth for next 5 years is recorded as 7.55%.
Verizon Communications Inc. (NYSE:VZ) announced that the company is partnering with Techweek, the nation’s leading technology conference, for an Emerging Cities Summit as part of Techweek Detroit 2015 from April 13 to April 19.
On Thursday shares of VIVUS Inc. (NASDAQ:VVUS) closed at $2.43. Company’s sales growth for last 5 years was 29.50% and EPS growth for next 5 years is recorded as 6.70%. On 30 March, VIVUS Inc. (NASDAQ:VVUS) announced an operational update, including certain key corporate decisions and plans regarding Qsymia® (phentermine and topiramate extended-release) capsules CIV. These plans include further investments in high-value, consumer-focused digital media projects in support of obesity education and Qsymia, and focusing the Qsymia field sales organization of approximately 100 territories on the most productive target areas.
On last trading day Bristol-Myers Squibb Company (NYSE:BMY) fell -0.52% to close at $63.23. Its volatility for the week is 1.68% while volatility for the month is 1.90%. BMY’s sales growth for past 5 years was -3.30% and its EPS growth for past 5 years was -5.90%. Bristol-Myers Squibb Company (NYSE:BMY) monthly performance is -3.16%. Bristol-Myers Squibb Company (NYSE:BMY) said that, it will announce results for the first quarter of 2015 on Tuesday, April 28, 2015.